Loading…
Natural Ginger, Corp/Jonaus Corp was cited for marketing six products—including ginger syrups, algae supplements, and vitamin formulations—with disease treatment and prevention claims that caused them to be classified as unapproved drugs rather than dietary supplements or foods. The company's website and Facebook page made specific claims that the products could treat coughs, alleviate inflammation, soothe sore throats, and provide antimicrobial benefits, which violated the Federal Food, Drug, and Cosmetic Act by establishing drug intent without FDA approval. The violation occurred through direct marketing claims on their website (naturgin.com) and social media directing consumers to purchase the products for therapeutic use.